Alan Gass

3.1k total citations
80 papers, 2.1k citations indexed

About

Alan Gass is a scholar working on Surgery, Biomedical Engineering and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Alan Gass has authored 80 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Surgery, 33 papers in Biomedical Engineering and 26 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Alan Gass's work include Transplantation: Methods and Outcomes (35 papers), Mechanical Circulatory Support Devices (30 papers) and Cardiac Structural Anomalies and Repair (24 papers). Alan Gass is often cited by papers focused on Transplantation: Methods and Outcomes (35 papers), Mechanical Circulatory Support Devices (30 papers) and Cardiac Structural Anomalies and Repair (24 papers). Alan Gass collaborates with scholars based in United States, China and Poland. Alan Gass's co-authors include Steven Lansman, David A. Baran, Wilbert S. Aronow, David Spielvogel, John T. Fallon, Tammy Tokarczyk, Guillermo Torre‐Amione, Paul Kessler, Arthur M. Feldman and Randall C. Starling and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and CHEST Journal.

In The Last Decade

Alan Gass

74 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Gass United States 20 1.1k 971 677 303 293 80 2.1k
José Tallaj United States 28 1.0k 0.9× 1.2k 1.2× 706 1.0× 210 0.7× 312 1.1× 128 2.5k
Maria Frigerio Italy 25 989 0.9× 1.6k 1.6× 502 0.7× 52 0.2× 263 0.9× 107 2.3k
Félix Pérez‐Villa Spain 30 995 0.9× 1.2k 1.3× 357 0.5× 72 0.2× 526 1.8× 141 2.7k
John B. OʼConnell United States 25 1.4k 1.3× 2.9k 3.0× 608 0.9× 71 0.2× 352 1.2× 70 3.7k
Lucy Thuita United States 31 1.5k 1.4× 345 0.4× 1.1k 1.7× 61 0.2× 164 0.6× 65 2.6k
Andrew Mitchell United Kingdom 24 937 0.9× 913 0.9× 263 0.4× 70 0.2× 282 1.0× 66 1.6k
T. W. Higenbottam United Kingdom 25 871 0.8× 525 0.5× 135 0.2× 538 1.8× 317 1.1× 57 2.3k
Tal Hasin Israel 25 831 0.8× 800 0.8× 678 1.0× 39 0.1× 103 0.4× 78 1.8k
Arvind Bhimaraj United States 24 779 0.7× 741 0.8× 775 1.1× 63 0.2× 159 0.5× 139 2.1k
José González‐Costello Spain 24 677 0.6× 905 0.9× 534 0.8× 55 0.2× 204 0.7× 134 1.8k

Countries citing papers authored by Alan Gass

Since Specialization
Citations

This map shows the geographic impact of Alan Gass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Gass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Gass more than expected).

Fields of papers citing papers by Alan Gass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Gass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Gass. The network helps show where Alan Gass may publish in the future.

Co-authorship network of co-authors of Alan Gass

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Gass. A scholar is included among the top collaborators of Alan Gass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Gass. Alan Gass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gass, Alan, Gregg M. Lanier, Avi Levine, et al.. (2025). Eculizumab Use in Highly Sensitized Heart Transplant Recipients. The Journal of Heart and Lung Transplantation. 44(4). S646–S646.
2.
Isath, Ameesh, Gregg M. Lanier, Avi Levine, et al.. (2024). Single‐center experience of extended brain‐death donor heart preservation with the organ care system. Artificial Organs. 49(1). 119–128. 1 indexed citations
3.
4.
Ohira, Suguru, Masashi Kai, Avi Levine, et al.. (2023). An Update on the Diagnosis and Management of Acute Right Heart Failure. Cardiology in Review. 32(6). 499–506. 1 indexed citations
5.
Ohira, Suguru, Stephen Pan, Avi Levine, et al.. (2022). High flow from Impella 5.5 with partial veno‐arterial extracorporeal membrane oxygenation support: Case series. Artificial Organs. 46(6). 1198–1203. 8 indexed citations
6.
Levine, Avi, Masashi Kai, Suguru Ohira, et al.. (2022). Ecpella 5.5. Cardiology in Review. Publish Ahead of Print. 5 indexed citations
7.
Ohira, Suguru, Stephen Pan, Avi Levine, et al.. (2021). Simple technique of distal leg perfusion during heart transplant in patients with preoperative veno-arterial extracorporeal membrane oxygenation support. Perfusion. 38(3). 473–476. 3 indexed citations
8.
9.
10.
Gass, Alan, et al.. (2019). UTILIZING ECMO FOR RECURRENT IDIOPATHIC VENTRICULAR FIBRILLATION. Journal of the American College of Cardiology. 73(9). 2598–2598.
11.
Rochlani, Yogita, et al.. (2018). HYDROXYCHLOROQUINE (PLAQUENIL) CARDIOTOXICITY: AN UNCOMMON COMPLICATION OF A COMMON MEDICATION. Journal of the American College of Cardiology. 71(11). A2395–A2395. 1 indexed citations
12.
Gass, Alan, Abbas Emaminia, Gregg M. Lanier, et al.. (2015). Cardiac Transplantation in the New Era. Cardiology in Review. 23(4). 182–188. 11 indexed citations
13.
Furqan, Muhammad, Akintunde Akinleye, Judy Sarungbam, et al.. (2014). Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock. Frontiers of Medicine. 8(2). 254–258. 2 indexed citations
14.
Lubitz, Steven A., Sean Pinney, Juan P. Wisnivesky, Alan Gass, & David A. Baran. (2007). Statin Therapy Associated With a Reduced Risk of Chronic Renal Failure After Cardiac Transplantation. The Journal of Heart and Lung Transplantation. 26(3). 264–272. 24 indexed citations
15.
Baran, David A., Mark Zucker, Luis H. Arroyo, et al.. (2007). Randomized Trial of Tacrolimus Monotherapy: Tacrolimus In Combination, Tacrolimus Alone Compared (The TICTAC Trial). The Journal of Heart and Lung Transplantation. 26(10). 992–997. 18 indexed citations
16.
Baran, David A., Luis H. Arroyo, Steven A. Lubitz, et al.. (2006). Is Toxoplasmosis Prophylaxis Necessary in Cardiac Transplantation? Long-term Follow-up at Two Transplant Centers. The Journal of Heart and Lung Transplantation. 25(11). 1380–1382. 25 indexed citations
17.
Baran, David A., Mark Zucker, Luis H. Arroyo, et al.. (2004). Can initial tacrolimus trough levels be predicted from clinical variables?. Transplantation Proceedings. 36(9). 2816–2818. 3 indexed citations
18.
Eng, Christine M., Maryam Banikazemi, Ronald E. Gordon, et al.. (2001). A Phase 1/2 Clinical Trial of Enzyme Replacement in Fabry Disease: Pharmacokinetic, Substrate Clearance, and Safety Studies. The American Journal of Human Genetics. 68(3). 711–722. 306 indexed citations
19.
Taylor, David O., Mark L. Barr, Bruno M. Meiser, et al.. (2001). Suggested guidelines for the use of tacrolimus in cardiac transplant recipients. The Journal of Heart and Lung Transplantation. 20(7). 734–738. 41 indexed citations
20.
Freudenberger, Ronald S., Jeffrey D. Alexis, Alan Gass, Valentı́n Fuster, & Juan J. Badimón. (1999). Antithrombotic effect of FK506 vs cyclosporine in cardiac transplant recipients: potential implications in transplant arteriopathy. The Journal of Heart and Lung Transplantation. 18(12). 1228–1231. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Tallaj Breakdown of academic impact, for papers by Maria Frigerio Breakdown of academic impact, for papers by Félix Pérez‐Villa Breakdown of academic impact, for papers by John B. OʼConnell Breakdown of academic impact, for papers by Lucy Thuita Breakdown of academic impact, for papers by Andrew Mitchell Breakdown of academic impact, for papers by T. W. Higenbottam Breakdown of academic impact, for papers by Tal Hasin Breakdown of academic impact, for papers by Arvind Bhimaraj Breakdown of academic impact, for papers by José González‐Costello
Rankless by CCL
2026